Top Links

Articles Related to analgesics

Descriptive Study of Exposure to Inhalation Zanamivir and Pregnancy-Related Outcomes

The Health Improvement Network (THIN) provided data from UK General Practitioners (GPs) for 144 pregnant women who were prescribed zanamivir and 144 age- and date-matched untreated comparators with no recorded diagnosis of influenza. Groups were assessed for baseline characteristics, treatment-emergent diagnoses in the mother, pregnancy outcomes and congenital malformations diagnosed in the offspring within 28 days of birth.
View complete article: PDF  |  Full-text

Thrombotic Microangiopathy Associated with Intravenous Injection Of Opana Er®: University Medical Center Case Series.

In response to the rapidly rising intravenous opioid abuse epidemic, the United States Food and Drug Administration is currently promoting the development of prescription opioid tablets that are specifically formulated to deter abuse. Opana ER® (Endo Pharmaceuticals) recently underwent reformulation to include a crush-resistant coating. Only recently described, illicit intravenous injection of reformulated Opana ER® is associated with a distinctive clinical syndrome of thrombotic microangiopathy.
View complete article: PDF  |  Full-text  | Digital
 
 


Editorial Board Members Related to analgesics

SEBASTIANO MERCADANTE

Director of Anesthesia & Intensive Care and Pain Relief & Supportive Care Unit
La Maddalena Cancer Center, Palermo
Italy

Esam Z. Dajani

Adjunct Professor of Medicine
Loyola University
USA

Joseph Pergolizzi

Adjunct Assistant Professor
Department of Medicine
Johns Hopkins University
United States
Submit Manuscript